Research output per year
Research output per year
Personal profile
In Korean
조희진 교수(첨단기술융합대학 의생명융합공학과)
Education
o (2011) B.A., Boston University, MA, USA
o (2017) Ph.D., Sungkyunkwan University
o (2017) Ph.D., Sungkyunkwan University
Professional Experience
o (2021~Present) Assistant Professor, Kyungpook National University
o (2018~2021) Senior Scientist, Samsung Medical Center
o (2017) Postdoctoral Researcher, Samsung Medical Center
o (2018~2021) Senior Scientist, Samsung Medical Center
o (2017) Postdoctoral Researcher, Samsung Medical Center
Research Interests
Bioinformatics, multi-omics, cancer genomics, tumor microenvironment, microbiome, precision medicine, in silico platform development
url
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Hee Jin Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comprehensive Transcriptomic Analysis Reveals Cell-Type-Specific Roles of Human Odorant Receptors in Glioblastoma and the Tumor Microenvironment
Cho, H. J., Yeo, D. J., Yang, H. W. & Koo, J. H., Dec 2024, In: International Journal of Molecular Sciences. 25, 24, 13382.Research output: Contribution to journal › Article › peer-review
Open Access -
Comprehensive Transcriptomic Profiling of Diverse Brain Tumor Types Uncovers Complex Structures of the Brain Tumor Microenvironment
Choi, J. & Cho, H. J., Mar 2024, In: Biomedicines. 12, 3, 506.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
Cho, H. J., Yun, K. H., Shin, S. J., Lee, Y. H., Kim, S. H., Baek, W., Han, Y. D., Kim, S. K., Ryu, H. J., Lee, J., Cho, I., Go, H., Ko, J., Jung, I., Jeon, M. K., Rha, S. Y. & Kim, H. S., Dec 2024, In: Nature Communications. 15, 1, 685.Research output: Contribution to journal › Article › peer-review
Open Access24 Scopus citations -
A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
Choi, S. W., Jung, H. A., Cho, H. J., Kim, T. M., Park, C. K., Nam, D. H. & Lee, S. H., Aug 2023, In: Cancer Medicine. 12, 15, p. 15788-15796 9 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
Lim, S. H., Cho, H. J., Kim, K. M., Lim, H. Y., Kang, W. K., Lee, J., Park, Y. S., Kim, H. C. & Kim, S. T., 2023, In: Oncology Research. 31, 6, p. 855-866 12 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations